Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Medtronic Minimed: medical device reports filed with FDA

442,554 reports name it as the manufacturer of the device involved, 2002–2026.

442,554
reports naming it as manufacturer
1.7% of all MAUDE reports
54,842
reports, 12 months to August 2026
62,244 in the 12 months before
84.7%
classified as malfunction
62.3% across all reports
0.4%
classified as death, as reported
0.9% across all reports

442,554 medical device reports received by FDA give Medtronic Minimed as the manufacturer of the device involved, 1.7% of the MAUDE database, from February 2002 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

54,842 reports arrived in the 12 months to August 2026, down 12% from 62,244 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (84.7%), injury (14.9%) and death (0.4%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Paradigm Real-Time Revel Insulin Infusion PumpPump, infusion, insulin, to be used with invasive glucose sensor61,17300.6%
Paradigm Real-Time Insulin Infusion PumpPump, infusion, insulin, to be used with invasive glucose sensor48,97300.3%
Transmitter Mmt-7841zn Gst5g UsSensor, glucose, invasive, non-adjunctive42,01014,1860%
Transmitter Mmt-7841zw Gst5g OusSensor, glucose, invasive, non-adjunctive31,56812,3510%
Smartphone Android App: Pump ConnectInsulin pump secondary display19,7652,7200%
Sensor EnliteAutomated insulin dosing , threshold suspend17,73400%
Xmtr MMT-7811NA GST3C LockoutAutomated insulin dosing device system, single hormonal control16,809650%
Xmtr Mmt-7811xww Gst3c OusAutomated insulin dosing device system, single hormonal control16,1321110%
Smartphone iOS App: Pump ConnectInsulin pump secondary display14,7641,1210%
Guardian Link 3 USAutomated insulin dosing device system, single hormonal control11,2232290%
Sensor Enlite Mmt-7008aAutomated insulin dosing , threshold suspend7,677130.3%
Guardian Link 3 OUSAutomated insulin dosing device system, single hormonal control6,6627330%
Unknown NGPAutomated insulin dosing device system, single hormonal control6,3513,9820.8%
Paradigm Insulin Infusion PumpPump, infusion, insulin6,18200.4%
Sensor Mmt-7040c1 Guardian4 5pk Ous 1Automated insulin dosing device system, single hormonal control5,6352,0070%
Sensor Mmt-7020a Enlite3 5pk UsAutomated insulin dosing device system, single hormonal control5,4621990.1%
Insulin Infusion PumpPump, infusion, insulin, to be used with invasive glucose sensor4,99702.6%
Unknown XMTRSensor, glucose, invasive4,4222,0270%
Carelink Personal Mmt-7333Sensor, glucose, invasive3,5132330%
Sensor Mmt-7040a Guardian4 5pk UsAutomated insulin dosing device system, single hormonal control3,4472,5310%
Reservoir 3mlPump, infusion2,90200.8%
Sensor Mmt-5120c Instinct 780 5pk Ous 1Sensor, glucose, invasive, non-adjunctive2,8771,6810%
Sensor Mmt-5120d1 Instinct 780 1pk Ous 1Sensor, glucose, invasive, non-adjunctive2,7171,7530%
Sensor Mmt-7020c1 Gs3 5pk 9l Ous1Automated insulin dosing device system, single hormonal control2,5204550%
530g Insulin PumpAutomated insulin dosing , threshold suspend2,24500.8%
Sensor Mmt-7040d1 Guardian4 1pk Ous 1Automated insulin dosing device system, single hormonal control2,0731,1100%
Carelink Connect app iOSInsulin pump secondary display1,8551260%
Sensor Mmt-5120d2 Instinct 780 1pk Ous 2Sensor, glucose, invasive, non-adjunctive1,7051,0620%
Sensor Enlite Mmt-7008bAutomated insulin dosing , threshold suspend1,66530%
Transmitter Mmt-7841qzw Gst5g Ous LckoutSensor, glucose, invasive, non-adjunctive1,6321870%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
OYCPump, infusion, insulin, to be used with invasive glucose sensor126,79328.7%
OZPAutomated insulin dosing device system, single hormonal control83,48118.9%
PQFSensor, glucose, invasive, non-adjunctive82,92918.7%
MDSSensor, glucose, invasive41,1259.3%
PKUInsulin pump secondary display38,0388.6%
OZOAutomated insulin dosing , threshold suspend30,3536.9%
LZGPump, infusion, insulin21,5124.9%
FRNPump, infusion4,8721.1%
SFISensor, glucose, invasive, component of automated insulin delivery system4,1340.9%
FPASet, administration, intravascular2,6050.6%

Reports by month, five years

08,93417,867Sep 2021: 421Oct 2021: 281Nov 2021: 257Dec 2021: 4672022Jan 2022: 254Feb 2022: 404Mar 2022: 10,742Apr 2022: 841May 2022: 1,477Jun 2022: 984Jul 2022: 2,710Aug 2022: 1,515Sep 2022: 3,767Oct 2022: 1,275Nov 2022: 2,539Dec 2022: 4,0772023Jan 2023: 17,867Feb 2023: 14,419Mar 2023: 3,007Apr 2023: 3,560May 2023: 2,129Jun 2023: 3,038Jul 2023: 3,560Aug 2023: 4,201Sep 2023: 2,729Oct 2023: 4,147Nov 2023: 4,096Dec 2023: 3,4802024Jan 2024: 5,426Feb 2024: 5,146Mar 2024: 3,405Apr 2024: 3,011May 2024: 4,731Jun 2024: 3,253Jul 2024: 3,897Aug 2024: 3,211Sep 2024: 3,737Oct 2024: 3,450Nov 2024: 4,001Dec 2024: 5,2502025Jan 2025: 6,569Feb 2025: 3,667Mar 2025: 4,470Apr 2025: 5,434May 2025: 5,932Jun 2025: 5,067Jul 2025: 7,601Aug 2025: 7,066Sep 2025: 9,252Oct 2025: 6,397Nov 2025: 5,218Dec 2025: 5,7702026Jan 2026: 4,376Feb 2026: 4,522Mar 2026: 3,801Apr 2026: 4,391May 2026: 2,855Jun 2026: 2,822Jul 2026: 2,865Aug 2026: 2,573

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0.4%1,569
Injury14.9%65,968
Malfunction84.7%374,707
Other0%22
Not given0.1%288

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Medtronic Minimed reports

How many FDA device reports name Medtronic Minimed as manufacturer?

442,554 reports through August 2026, 54,842 of them in the latest 12 months.

Which of its brands appear most often?

Paradigm Real-Time Revel Insulin Infusion Pump (61,173), Paradigm Real-Time Insulin Infusion Pump (48,973), Transmitter Mmt-7841zn Gst5g Us (42,010), Transmitter Mmt-7841zw Gst5g Ous (31,568) and Smartphone Android App: Pump Connect (19,765).

Which device types does it report on?

pump, infusion, insulin, to be used with invasive glucose sensor (28.7%), automated insulin dosing device system, single hormonal control (18.9%), sensor, glucose, invasive, non-adjunctive (18.7%) and sensor, glucose, invasive (9.3%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.